We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$9.13B
AUM Growth
+$334M
Cap. Flow
-$281M
Cap. Flow %
-3.08%
Top 10 Hldgs %
21.52%
Holding
2,368
New
73
Increased
154
Reduced
1,152
Closed
75

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.6M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$3.94M
3
CZR icon
Caesars Entertainment
CZR
+$3.71M
4
IAA
IAA, Inc. Common Stock
IAA
+$3.57M
5
RUN icon
Sunrun
RUN
+$3.42M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$22.2M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$15.9M
3
MSFT icon
Microsoft
MSFT
+$13.6M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$9.6M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$9.15M

Sector Composition

Rank Sector Weight
1 Technology 22.17%
2 Healthcare 13.84%
3 Financials 12.41%
4 Consumer Discretionary 11.36%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMRE icon
2151
Costamare
CMRE
$1.71B
$115K ﹤0.01%
19,016
– –
PKE icon
2152
Park Aerospace
PKE
$828M
$115K ﹤0.01%
10,569
– –
TDW icon
2153
Tidewater
TDW
$4.56B
$115K ﹤0.01%
17,119
– –
PRTK
2154
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$115K ﹤0.01%
21,203
-270
-1% -$1.34K
CSTE icon
2155
Caesarstone
CSTE
$104M
$115K ﹤0.01%
11,687
– –
DSKE
2156
DELISTED
Daseke, Inc. Common Stock
DSKE
$114K ﹤0.01%
+21,286
New +$109K
SSTI icon
2157
SoundThinking
SSTI
$106M
$114K ﹤0.01%
3,681
+58
+2% +$1.59K
CBMG
2158
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$114K ﹤0.01%
+6,205
New +$104K
AVID
2159
DELISTED
Avid Technology Inc
AVID
$114K ﹤0.01%
13,287
– –
HAYN
2160
DELISTED
Haynes International, Inc.
HAYN
$114K ﹤0.01%
6,653
– –
VYGR icon
2161
Voyager Therapeutics
VYGR
$197M
$114K ﹤0.01%
10,649
– –
EQBK icon
2162
Equity Bancshares
EQBK
$1.06B
$113K ﹤0.01%
7,293
– –
RIGL icon
2163
Rigel Pharmaceuticals
RIGL
$782M
$113K ﹤0.01%
4,709
-3,390
-42% -$83.2K
PRTS icon
2164
CarParts.com
PRTS
$51.3M
$113K ﹤0.01%
+1,044
New +$128K
DXPE icon
2165
DXP Enterprises
DXPE
$3.04B
$113K ﹤0.01%
6,978
– –
AKTS
2166
DELISTED
Akoustis Technologies Inc
AKTS
$112K ﹤0.01%
13,764
– –
GDEN
2167
DELISTED
Golden Entertainment
GDEN
$112K ﹤0.01%
+8,119
New +$91K
ANIP icon
2168
ANI Pharmaceuticals
ANIP
$1.73B
$111K ﹤0.01%
3,945
– –
PLRX icon
2169
Pliant Therapeutics
PLRX
$66.3M
$110K ﹤0.01%
+4,875
New +$122K
PARR icon
2170
Par Pacific Holdings
PARR
$3.9B
$110K ﹤0.01%
16,282
– –
MNOV icon
2171
MediciNova
MNOV
$65.5M
$110K ﹤0.01%
21,034
– –
WT icon
2172
WisdomTree
WT
$3.44B
$110K ﹤0.01%
34,418
-50,510
-59% -$182K
AXTI icon
2173
AXT Inc
AXTI
$5.13B
$110K ﹤0.01%
+17,988
New +$91.4K
NPTN
2174
DELISTED
NEOPHOTONICS CORP
NPTN
$110K ﹤0.01%
18,042
-9,828
-35% -$75K
OPY icon
2175
Oppenheimer Holdings
OPY
$1.23B
$109K ﹤0.01%
+4,905
New +$114K
85 86
87
88 89

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, MetLife Investment Management held 2,368 positions worth $9.13B, up 3.8% from $8.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management withdrew a net $281M in Q3 2020, closing 75 positions and reducing 1,152 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $7.44M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Jazz Pharmaceuticals worth $4.53M.

  • MetLife Investment Management's largest Q3 2020 buy was Jazz Pharmaceuticals: 31,753 shares worth $4.53M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $34.6M increase.
  • MetLife Investment Management's biggest Q3 2020 reduction was Apple, cutting an estimated $22.2M.
  • MetLife Investment Management fully exited Slack Technologies, Inc. in Q3 2020, selling an estimated $7.44M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $9.13B portfolio in Q3 2020.
  • MetLife Investment Management opened 73 new positions and closed 75 in Q3 2020.
  • MetLife Investment Management's portfolio value rose 3.8% quarter-over-quarter to $9.13B.

Based on MetLife Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.